<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35933347</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1475-2840</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>06</Day></PubDate></JournalIssue><Title>Cardiovascular diabetology</Title><ISOAbbreviation>Cardiovasc Diabetol</ISOAbbreviation></Journal><ArticleTitle>Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC).</ArticleTitle><Pagination><StartPage>148</StartPage><MedlinePgn>148</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">148</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12933-022-01579-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Fibrin(ogen) amyloid microclots and platelet hyperactivation previously reported as a novel finding in South African patients with the coronavirus 2019 disease (COVID-19) and Long COVID/Post-Acute Sequelae of COVID-19 (PASC), might form a suitable set of foci for the clinical treatment of the symptoms of Long COVID/PASC. A Long COVID/PASC Registry was subsequently established as an online platform where patients can report Long COVID/PASC symptoms and previous comorbidities.</AbstractText><AbstractText Label="METHODS">In this study, we report on the comorbidities and persistent symptoms, using data obtained from 845 South African Long COVID/PASC patients. By using a previously published scoring system for fibrin amyloid microclots and platelet pathology, we also analysed blood samples from 80 patients, and report the presence of significant fibrin amyloid microclots and platelet pathology in all cases.</AbstractText><AbstractText Label="RESULTS">Hypertension, high cholesterol levels (dyslipidaemia), cardiovascular disease and type 2 diabetes mellitus (T2DM) were found to be the most important comorbidities. The gender balance (70% female) and the most commonly reported Long COVID/PASC symptoms (fatigue, brain fog, loss of concentration and forgetfulness, shortness of breath, as well as joint and muscle pains) were comparable to those reported elsewhere. These findings confirmed that our sample was not atypical. Microclot and platelet pathologies were associated with Long COVID/PASC symptoms that persisted after the recovery from acute COVID-19.</AbstractText><AbstractText Label="CONCLUSIONS">Fibrin amyloid microclots that block capillaries and inhibit the transport of O<sub>2</sub> to tissues, accompanied by platelet hyperactivation, provide a ready explanation for the symptoms of Long COVID/PASC. Removal and reversal of these underlying endotheliopathies provide an important treatment option that urgently warrants controlled clinical studies to determine efficacy in patients with a diversity of comorbidities impacting on SARS-CoV-2 infection and COVID-19 severity. We suggest that our platelet and clotting grading system provides a simple and cost-effective diagnostic method for early detection of Long COVID/PASC as a major determinant of effective treatment, including those focusing on reducing clot burden and platelet hyperactivation.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pretorius</LastName><ForeName>Etheresia</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9108-2384</Identifier><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Private Bag X1, Matieland, Stellenbosch, 7602, South Africa. resiap@sun.ac.za.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Systems Biology, Faculty of Health and Life Sciences, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK. resiap@sun.ac.za.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venter</LastName><ForeName>Chantelle</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Private Bag X1, Matieland, Stellenbosch, 7602, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laubscher</LastName><ForeName>Gert Jacobus</ForeName><Initials>GJ</Initials><AffiliationInfo><Affiliation>Mediclinic Stellenbosch, Stellenbosch, 7600, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotze</LastName><ForeName>Maritha J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of Chemical Pathology, Department of Pathology, National Health Laboratory Service, Tygerberg Hospital &amp; Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, 8000, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oladejo</LastName><ForeName>Sunday O</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Centre for AI Research, School for Data-Science &amp; Computational Thinking, Stellenbosch University, Stellenbosch, 7600, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>Liam R</ForeName><Initials>LR</Initials><Identifier Source="ORCID">0000-0002-7016-9229</Identifier><AffiliationInfo><Affiliation>Centre for AI Research, School for Data-Science &amp; Computational Thinking, Stellenbosch University, Stellenbosch, 7600, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajaratnam</LastName><ForeName>Kanshu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Centre for AI Research, School for Data-Science &amp; Computational Thinking, Stellenbosch University, Stellenbosch, 7600, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>Bruce W</ForeName><Initials>BW</Initials><Identifier Source="ORCID">0000-0003-0511-1837</Identifier><AffiliationInfo><Affiliation>Centre for AI Research, School for Data-Science &amp; Computational Thinking, Stellenbosch University, Stellenbosch, 7600, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kell</LastName><ForeName>Douglas B</ForeName><Initials>DB</Initials><Identifier Source="ORCID">0000-0001-5838-7963</Identifier><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Private Bag X1, Matieland, Stellenbosch, 7602, South Africa. dbk@liv.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Systems Biology, Faculty of Health and Life Sciences, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK. dbk@liv.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Centre for Biosustainability, Technical University of Denmark, Kemitorvet 200, 2800, Kgs Lyngby, Denmark. dbk@liv.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cardiovasc Diabetol</MedlineTA><NlmUniqueID>101147637</NlmUniqueID><ISSNLinking>1475-2840</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9001-31-4</RegistryNumber><NameOfSubstance UI="D005337">Fibrin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="N">Amyloid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005337" MajorTopicYN="N">Fibrin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyloid fibrin(ogen)</Keyword><Keyword MajorTopicYN="N">Co-morbidities</Keyword><Keyword MajorTopicYN="N">Fluorescence microscopy</Keyword><Keyword MajorTopicYN="N">Hyperactivated platelets</Keyword><Keyword MajorTopicYN="N">Long COVID/PASC</Keyword><Keyword MajorTopicYN="N">Symptoms</Keyword></KeywordList><CoiStatement>MK is a non-executive director and shareholder of Gknowmix (Pty) Ltd. EP is the managing director of BioCODE Technologies. The other authors have no competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>6</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35933347</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pii">10.1186/s12933-022-01579-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A, Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Res Sq. 2021;11(1):1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As their numbers grow, COVID-19 &#x201c;long haulers&#x201d; stump experts. JAMA. 2020;324(14):1381&#x2013;1383. doi: 10.1001/jama.2020.17709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17709</ArticleId><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AM. Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers. J Med Virol. 2020 doi: 10.1002/jmv.26624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or Post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: is the worst yet to come? Med Hypotheses. 2021;146:110469. doi: 10.1016/j.mehy.2020.110469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110469</ArticleId><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohabbat AB, Mohabbat NML, Wight EC. Fibromyalgia and chronic fatigue syndrome in the age of COVID-19. Mayo Clin Proc Innov Qual Outcomes. 2020;4(6):764&#x2013;766. doi: 10.1016/j.mayocpiqo.2020.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocpiqo.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7661943</ArticleId><ArticleId IdType="pubmed">33204998</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein DS. The possible association between COVID-19 and postural tachycardia syndrome. Heart Rhythm. 2021;18(4):508&#x2013;509. doi: 10.1016/j.hrthm.2020.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2020.12.007</ArticleId><ArticleId IdType="pmc">PMC7729277</ArticleId><ArticleId IdType="pubmed">33316414</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327&#x2013;332. doi: 10.1016/j.ijid.2020.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Bateman L. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med (Lausanne) 2020;7:606824. doi: 10.3389/fmed.2020.606824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.606824</ArticleId><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB. Prevalence of readily detected amyloid blood clots in &#x2018;unclotted&#x2019; Type 2 diabetes mellitus and COVID-19 plasma: a preliminary report. Cardiovasc Diabetol. 2020;19(1):193. doi: 10.1186/s12933-020-01165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01165-7</ArticleId><ArticleId IdType="pmc">PMC7670290</ArticleId><ArticleId IdType="pubmed">33203441</ArticleId></ArticleIdList></Reference><Reference><Citation>Venter C, Bezuidenhout JA, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB, Pretorius E. Erythrocyte, platelet, serum ferritin, and P-selectin pathophysiology implicated in severe hypercoagulation and vascular complications in COVID-19. Int J Mol Sci. 2020;21(21):8234. doi: 10.3390/ijms21218234.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218234</ArticleId><ArticleId IdType="pmc">PMC7662625</ArticleId><ArticleId IdType="pubmed">33153161</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunch CM, Moore EE, Moore HB, Neal MD, Thomas AV, Zackariya N, Zhao J, Zackariya S, Brenner TJ, Berquist M, et al. Immuno-thrombotic complications of COVID-19: implications for timing of surgery and anticoagulation. Front Surg. 2022 doi: 10.3389/fsurg.2022.889999.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fsurg.2022.889999</ArticleId><ArticleId IdType="pmc">PMC9119324</ArticleId><ArticleId IdType="pubmed">35599794</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, laubscher GJ, Steenkamp J, Kell DB. Persistent clotting protein pathology in Long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J. 2022;479(4):537&#x2013;559. doi: 10.1042/BCJ20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams B, Nunes JM, Page MJ, Roberts T, Carr J, Nell TA, Kell DB, Pretorius E. Parkinson&#x2019;s disease: a systemic inflammatory disease accompanied by bacterial inflammagens. Front Aging Neurosci. 2019;11:210. doi: 10.3389/fnagi.2019.00210.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2019.00210</ArticleId><ArticleId IdType="pmc">PMC6718721</ArticleId><ArticleId IdType="pubmed">31507404</ArticleId></ArticleIdList></Reference><Reference><Citation>de Waal GM, Engelbrecht L, Davis T, de Villiers WJS, Kell DB, Pretorius E. Correlative light-electron microscopy detects lipopolysaccharide and its association with fibrin fibres in Parkinson's disease, Alzheimer's disease and type 2 diabetes mellitus. Sci Rep. 2018;8(1):16798. doi: 10.1038/s41598-018-35009-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-35009-y</ArticleId><ArticleId IdType="pmc">PMC6235901</ArticleId><ArticleId IdType="pubmed">30429533</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Pretorius E. The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen) Integr Biol. 2015;7:24&#x2013;52. doi: 10.1039/c4ib00173g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c4ib00173g</ArticleId><ArticleId IdType="pubmed">25335120</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Pretorius E. Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting. Prog Biophys Mol Biol. 2017;123:16&#x2013;41. doi: 10.1016/j.pbiomolbio.2016.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2016.08.006</ArticleId><ArticleId IdType="pubmed">27554450</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, Thomson GJA, Nunes JM, Engelbrecht AM, Nell TA, de Villiers WJS, de Beer MC, Engelbrecht L, Kell DB, Pretorius E. Serum amyloid A binds to fibrin(ogen), promoting fibrin amyloid formation. Sci Rep. 2019;9(1):3102. doi: 10.1038/s41598-019-39056-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39056-x</ArticleId><ArticleId IdType="pmc">PMC6395759</ArticleId><ArticleId IdType="pubmed">30816210</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Mbotwe S, Kell DB. Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities. Sci Rep. 2017;7(1):9680. doi: 10.1038/s41598-017-09860-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09860-4</ArticleId><ArticleId IdType="pmc">PMC5574907</ArticleId><ArticleId IdType="pubmed">28851981</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Page MJ, Engelbrecht L, Ellis GC, Kell DB. Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains. Cardiovasc Diabetol. 2017;16(1):141. doi: 10.1186/s12933-017-0624-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-017-0624-5</ArticleId><ArticleId IdType="pmc">PMC5668975</ArticleId><ArticleId IdType="pubmed">29096623</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Page MJ, Mbotwe S, Kell DB. Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson&#x2019;s disease. PLoS ONE. 2018;13(3):e0192121. doi: 10.1371/journal.pone.0192121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0192121</ArticleId><ArticleId IdType="pmc">PMC5832207</ArticleId><ArticleId IdType="pubmed">29494603</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar LM, Venter C, Vlok M, Ngoepe M, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB, Pretorius E. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci Rep. 2021;41(8):BSR20210611. doi: 10.1042/BSR20210611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaller J, Gerber SS. The plasmin&#x2013;antiplasmin system: structural and functional aspects. Cell Mol Life Sci. 2011;68(5):785&#x2013;801. doi: 10.1007/s00018-010-0566-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-010-0566-5</ArticleId><ArticleId IdType="pmc">PMC11115092</ArticleId><ArticleId IdType="pubmed">21136135</ArticleId></ArticleIdList></Reference><Reference><Citation>Miszta A, Huskens D, Donkervoort D, Roberts MJM, Wolberg AS, de Laat B. Assessing plasmin generation in health and disease. Int J Mol Sci. 2021;22(5):2758. doi: 10.3390/ijms22052758.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052758</ArticleId><ArticleId IdType="pmc">PMC7963172</ArticleId><ArticleId IdType="pubmed">33803235</ArticleId></ArticleIdList></Reference><Reference><Citation>Laubscher GJ, Lourens PJ, Venter C, Kell DB, Pretorius E. TEG&#xae;, microclot and platelet mapping for guiding early management of severe COVID-19 coagulopathy. J Clin Med. 2021;10:5381. doi: 10.3390/jcm10225381.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10225381</ArticleId><ArticleId IdType="pmc">PMC8621180</ArticleId><ArticleId IdType="pubmed">34830660</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluyver T, Ragan-Kelley B, P&#xc8;rez F, Granger BE, Bussonnier M, Frederic J, Kelley K, Hamrick JB, Grout J, Corlay S, et al. Jupyter notebooks&#x2014;a publishing format for reproducible computational workflows. In: ELPUB: 2016; 2016.</Citation></Reference><Reference><Citation>McKinney W. Data structures for statistical computing in python. In: Proceedings of the 9th python in science conference, 2010.</Citation></Reference><Reference><Citation>Kuznetsov S, Watson BW. Algorithmic support for knowledge discovery techniques based on formal concept analysis. In: CEUR Workshop Series, Vol. 1552; 2015.</Citation></Reference><Reference><Citation>Valente CC, Bauer FF, Venter F, Watson B, Nieuwoudt HH. Modelling the sensory space of varietal wines: mining of large, unstructured text data and visualisation of style patterns. Sci Rep. 2018;8(1):4987. doi: 10.1038/s41598-018-23347-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23347-w</ArticleId><ArticleId IdType="pmc">PMC5862899</ArticleId><ArticleId IdType="pubmed">29563535</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobler C, Maphumulo SC, Grobbelaar LM, Bredenkamp JC, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB, Pretorius E. Covid-19: the rollercoaster of fibrin(ogen), D-dimer, von willebrand factor, P-selectin and their interactions with endothelial cells, platelets and erythrocytes. Int J Mol Sci. 2020;21(14):5168. doi: 10.3390/ijms21145168.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21145168</ArticleId><ArticleId IdType="pmc">PMC7403995</ArticleId><ArticleId IdType="pubmed">32708334</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart S, Newson L, Briggs TA, Grammatopoulos D, Young L, Gill P. Long COVID risk&#x2014;a signal to address sex hormones and women's health. Lancet Reg Health Eur. 2021;11:100242. doi: 10.1016/j.lanepe.2021.100242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100242</ArticleId><ArticleId IdType="pmc">PMC8561426</ArticleId><ArticleId IdType="pubmed">34746909</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, Gillesen A, Berry C, Lowe DJ, McPeake J, et al. Long covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health Eur. 2021;8:100186. doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiura T, Dohi Y, Yamashita S, Yamamoto K, Wakamatsu Y, Tanaka S, Kimura G. Impact of lipid profile and high blood pressure on endothelial damage. J Clin Lipidol. 2011;5(6):460&#x2013;466. doi: 10.1016/j.jacl.2011.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacl.2011.06.005</ArticleId><ArticleId IdType="pubmed">22108149</ArticleId></ArticleIdList></Reference><Reference><Citation>Hurtubise J, McLellan K, Durr K, Onasanya O, Nwabuko D, Ndisang JF. The different facets of dyslipidemia and hypertension in atherosclerosis. Curr Atheroscler Rep. 2016;18(12):82. doi: 10.1007/s11883-016-0632-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11883-016-0632-z</ArticleId><ArticleId IdType="pubmed">27822682</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Mbotwe S, Bester J, Robinson CJ, Kell DB. Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide. J R Soc Interface. 2016;123(13):20160539. doi: 10.1098/rsif.2016.0539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2016.0539</ArticleId><ArticleId IdType="pmc">PMC5046953</ArticleId><ArticleId IdType="pubmed">27605168</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Bester J. Viscoelasticity as a measurement of clot structure in poorly controlled type 2 diabetes patients: towards a precision and personalized medicine approach. Oncotarget. 2016;7(32):50895&#x2013;50907. doi: 10.18632/oncotarget.10618.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.10618</ArticleId><ArticleId IdType="pmc">PMC5239445</ArticleId><ArticleId IdType="pubmed">27447972</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Bester J, Vermeulen N, Alummoottil S, Soma P, Buys AV, Kell DB. Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics. Cardiovasc Diabetol. 2015;14:30. doi: 10.1186/s12933-015-0192-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-015-0192-5</ArticleId><ArticleId IdType="pmc">PMC4364097</ArticleId><ArticleId IdType="pubmed">25848817</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Lipinski B, Bester J, Vermeulen N, Soma P. Albumin stabilizes fibrin fiber ultrastructure in low serum albumin type 2 diabetes. Ultrastruct Pathol. 2013;37(4):254&#x2013;257. doi: 10.3109/01913123.2013.778929.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01913123.2013.778929</ArticleId><ArticleId IdType="pubmed">23672265</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Oberholzer HM, van der Spuy WJ, Swanepoel AC, Soma P. Qualitative scanning electron microscopy analysis of fibrin networks and platelet abnormalities in diabetes. Blood Coagul Fibrinolysis. 2011;22(6):463&#x2013;467. doi: 10.1097/MBC.0b013e3283468a0d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e3283468a0d</ArticleId><ArticleId IdType="pubmed">21467917</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Bester J, Page MJ, Kell DB. The potential of LPS-binding protein to reverse amyloid formation in plasma fibrin of individuals with Alzheimer-type dementia. Front Aging Neurosci. 2018;10:257. doi: 10.3389/fnagi.2018.00257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00257</ArticleId><ArticleId IdType="pmc">PMC6113936</ArticleId><ArticleId IdType="pubmed">30186156</ArticleId></ArticleIdList></Reference><Reference><Citation>Bester J, Soma P, Kell DB, Pretorius E. Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS) Oncotarget. 2015;6(34):35284&#x2013;35303. doi: 10.18632/oncotarget.6074.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.6074</ArticleId><ArticleId IdType="pmc">PMC4742105</ArticleId><ArticleId IdType="pubmed">26462180</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen VG, Pretorius E, Bester J, Jacobsen WK, Boyle PK, Reinhard JP. Carbon monoxide and iron modulate plasmatic coagulation in Alzheimer's disease. Curr Neurovasc Res. 2015;12(1):31&#x2013;39. doi: 10.2174/1567202612666150102150042.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567202612666150102150042</ArticleId><ArticleId IdType="pubmed">25557378</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Humphries P. Ultrastructural changes to rabbit fibrin and platelets due to aspartame. Ultrastruct Pathol. 2007;31(2):77&#x2013;83. doi: 10.1080/01913120701376105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01913120701376105</ArticleId><ArticleId IdType="pubmed">17613990</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Oberholzer HM. Ultrastructural changes of platelets and fibrin networks in human asthma: a qualitative case study. Blood Coagul Fibrinol. 2009;20(2):146&#x2013;149. doi: 10.1097/MBC.0b013e328325549a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e328325549a</ArticleId><ArticleId IdType="pubmed">19786943</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Bronkhorst P, Briedenhann S, Smit E, Franz RC. Comparisons of the fibrin networks during pregnancy, nonpregnancy and pregnancy during dysfibrinogenaemia using the scanning electron microscope. Blood Coagul Fibrinol. 2009;20(1):12&#x2013;16. doi: 10.1097/MBC.0b013e328322b429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e328322b429</ArticleId><ArticleId IdType="pubmed">20527721</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Windberger UB, Oberholzer HM, Auer RE. Comparative ultrastructure of fibrin networks of a dog after thrombotic ischaemic stroke. Onderstepoort J Vet Res. 2010;77(1):E1&#x2013;E4. doi: 10.4102/ojvr.v77i1.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.4102/ojvr.v77i1.4</ArticleId><ArticleId IdType="pubmed">23327160</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Oberholzer HM, van der Spuy WJ, Meiring JH. The changed ultrastructure of fibrin networks during use of oral contraception and hormone replacement. J Thromb Thrombolysis. 2010;30(4):502&#x2013;506. doi: 10.1007/s11239-010-0502-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-010-0502-4</ArticleId><ArticleId IdType="pubmed">20640484</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E. The use of a desktop scanning electron microscope as a diagnostic tool in studying fibrin networks of thrombo-embolic ischemic stroke. Ultrastruct Pathol. 2011;35(6):245&#x2013;250. doi: 10.3109/01913123.2011.606659.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01913123.2011.606659</ArticleId><ArticleId IdType="pubmed">21932989</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vermeulen N, Bester J, Lipinski B, Kell DB. A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy. Toxicol Mech Methods. 2013;23(5):352&#x2013;359. doi: 10.3109/15376516.2012.762082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15376516.2012.762082</ArticleId><ArticleId IdType="pubmed">23278212</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Kell DB. Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases. Integr Biol. 2014;6(5):486&#x2013;510. doi: 10.1039/C4IB00025K.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4IB00025K</ArticleId><ArticleId IdType="pubmed">24714688</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Bester J, Kell DB. A bacterial component to Alzheimer-type dementia seen via a systems biology approach that links iron dysregulation and inflammagen shedding to disease. J Alzheimers Dis. 2016;53(4):1237&#x2013;1256. doi: 10.3233/JAD-160318.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160318</ArticleId><ArticleId IdType="pmc">PMC5325058</ArticleId><ArticleId IdType="pubmed">27340854</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E. Platelets in HIV: a guardian of host defence or transient reservoir of the virus? Front Immunol. 2021 doi: 10.3389/fimmu.2021.649465.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.649465</ArticleId><ArticleId IdType="pmc">PMC8102774</ArticleId><ArticleId IdType="pubmed">33968041</ArticleId></ArticleIdList></Reference><Reference><Citation>Daramola O, Nyasulu P, Mashamba-Thompson T, Moser T, Broomhead S, Hamid A, Naidoo J, Whati L, Kotze MJ, Stroetmann K, et al. Towards AI-enabled multimodal diagnostics and management of COVID-19 and comorbidities in resource-limited settings. Informatics. 2021;8(4):63. doi: 10.3390/informatics8040063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/informatics8040063</ArticleId></ArticleIdList></Reference><Reference><Citation>Jongeneel CV, Kotze MJ, Bhaw-Luximon A, Fadlelmola FM, Fakim YJ, Hamdi Y, Kassim SK, Kumuthini J, Nembaware V, Radouani F, et al. A view on genomic medicine activities in Africa: implications for policy. Front Genet. 2022;13:836. doi: 10.3389/fgene.2022.769919.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.769919</ArticleId><ArticleId IdType="pmc">PMC9091728</ArticleId><ArticleId IdType="pubmed">35571023</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>